U.S. federal trademark · Serial No. 97458378 · Reg. No. 7167553
Development of new technology for others in the field of newborn genomic sequencing for the purpose of ending diagnostic odyssey; Providing a website featuring technology that enabling physicians to access resources for effective treatment options for newborns with genetic diseases
Newborn genomic sequencing services, namely, medical testing for diagnostic or treatment purposes to end the diagnostic odyssey; providing medical screening for detecting genetic diseases in newborns
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.